Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Mónica Villa-Álvarez"'
Autor:
Seila Lorenzo-Herrero, Christian Sordo-Bahamonde, Gabriel Bretones, Ángel R. Payer, Ana P. González-Rodríguez, Esther González-García, Jhudit Pérez-Escuredo, Mónica Villa-Álvarez, Luz-Elena Núñez, Francisco Morís, Segundo Gonzalez, Alejandro López-Soto
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
B-cell receptor (BCR)-dependent signaling is central for leukemia B-cell homeostasis, as underscored by the promising clinical results obtained in patients with chronic lymphocytic leukemia (CLL) treated with novel agents targeting components of this
Externí odkaz:
https://doaj.org/article/c9308b239ec243ad9b6907c1bcabb68e
Autor:
Mónica Villa-Álvarez, Christian Sordo-Bahamonde, Seila Lorenzo-Herrero, Ana P. Gonzalez-Rodriguez, Angel R. Payer, Esther Gonzalez-Garcia, María C. Villa-Álvarez, Alejandro López-Soto, Segundo Gonzalez
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
One of the cardinal features of chronic lymphocytic leukemia (CLL) is its association with a profound immunosuppression. NK cell function is markedly impaired in CLL patients, who show a significant dysregulation of the expression of activating and i
Externí odkaz:
https://doaj.org/article/089be14244b7465dabdb01bb0d85250d
Autor:
Mónica Villa-Álvarez, Seila Lorenzo-Herrero, Ana P. Gonzalez-Rodriguez, Alejandro López-Soto, Angel R. Payer, Esther Gonzalez-Garcia, Leticia Huergo-Zapico, Segundo Gonzalez
Publikováno v:
OncoImmunology, Vol 6, Iss 10 (2017)
Chronic lymphocytic leukemia (CLL) is associated with a profound dysregulation of the immune system. Loss of T cell function is frequently caused in cancer by sustained signaling of inhibitory receptors. Here, we analyzed the role of the novel inhibi
Externí odkaz:
https://doaj.org/article/523b813c33e24422bcd9885b4fbdffcf
Autor:
Azahara Fernández-Guizán, Alejandro López-Soto, Andrea Acebes-Huerta, Leticia Huergo-Zapico, Mónica Villa-Álvarez, Luz-Elena Núñez, Francisco Morís, Segundo Gonzalez
Publikováno v:
PLoS ONE, Vol 10, Iss 11, p e0140786 (2015)
Demycarosyl-3D-ß-D-digitoxosyl-mithramycin SK (DIG-MSK) is a recently isolated analogue of mithramycin A (MTA) that showed differences with MTA in the DNA binding strength and selectivity. These differences correlated with a better therapeutic index
Externí odkaz:
https://doaj.org/article/83710cf680c6406cb141edd759977f02
Autor:
Segundo Gonzalez, Ana P Gonzalez-Rodriguez, Mónica Villa-Álvarez, Christian Sordo-Bahamonde, Seila Lorenzo-Herrero
Publikováno v:
Journal of Clinical Medicine, Vol 8, Iss 10, p 1557 (2019)
WOS:000498398500055
RUO. Repositorio Institucional de la Universidad de Oviedo
Scipedia SL
Journal of Clinical Medicine
WOS:000498398500055
RUO. Repositorio Institucional de la Universidad de Oviedo
Scipedia SL
Journal of Clinical Medicine
Natural killer (NK) cells have the innate ability to kill cancer cells, however, tumor cells may acquire the capability of evading the immune response, thereby leading to malignancies. Restoring or potentiation of this natural antitumor activity of N
Autor:
Seila Lorenzo-Herrero, Segundo Gonzalez, Esther González-García, Ana P Gonzalez-Rodriguez, Angel Ramirez Payer, Alejandro López-Soto, Mónica Villa-Álvarez, Leticia Huergo-Zapico
Publikováno v:
OncoImmunology, Vol 6, Iss 10 (2017)
Chronic lymphocytic leukemia (CLL) is associated with a profound dysregulation of the immune system. Loss of T cell function is frequently caused in cancer by sustained signaling of inhibitory receptors. Here, we analyzed the role of the novel inhibi
Autor:
Segundo Gonzalez, Mónica Villa-Álvarez, Leticia Huergo-Zapico, Andrea Acebes-Huerta, Alejandro López-Soto
Publikováno v:
International Journal of Cancer. 136:1741-1750
The immune system is able to detect and eliminate transformed cells. The activating receptor NKG2D is particularly relevant for cancer immunosurveillance. NKG2D ligand expression renders tumor cells more susceptible to be killed by NK and T cells, an
Autor:
Segundo Gonzalez, Angel Ramirez Payer, Ana P Gonzalez-Rodriguez, Esther González-García, Mónica Villa-Álvarez, Andrea Acebes-Huerta, Leticia Huergo-Zapico
Publikováno v:
BioMed Research International, Vol 2013 (2013)
WOK
BioMed Research International
RUO. Repositorio Institucional de la Universidad de Oviedo
instname
WOK
BioMed Research International
RUO. Repositorio Institucional de la Universidad de Oviedo
instname
Lenalidomide is an oral immunomodulatory drug used in multiple myeloma and myelodysplastic syndrome and most recently it has shown to be effective in the treatment of various lymphoproliferative disorders such as chronic lymphocytic leukemia (CLL) an
Autor:
Esther González-García, Segundo Gonzalez, Angel Ramirez Payer, Andrea Acebes-Huerta, Azahara Fernández-Guizán, Ana P Gonzalez-Rodriguez, Juan Contesti, Alejandro López-Soto, Leticia Huergo-Zapico, Mónica Villa-Álvarez
Publikováno v:
PLoS ONE
Scopus
RUO. Repositorio Institucional de la Universidad de Oviedo
instname
PLoS ONE, Vol 9, Iss 10, p e108326 (2014)
Scopus
RUO. Repositorio Institucional de la Universidad de Oviedo
instname
PLoS ONE, Vol 9, Iss 10, p e108326 (2014)
The immune system may mediate anti-tumor responses in chronic lymphocytic leukemia (CLL) which may affect disease progression and survival. In this study, we analyzed the immune characteristics of 99 consecutive previously diagnosed CLL patients and
Autor:
Leticia Huergo-Zapico, Andrea Acebes-Huerta, Ana Pilar Gonzalez-Rodriguez, Juan Contesti, Esther Gonzalez-García, Angel R Payer, Monica Villa-Alvarez, Azahara Fernández-Guizán, Alejandro López-Soto, Segundo Gonzalez
Publikováno v:
PLoS ONE, Vol 9, Iss 10, p e108326 (2014)
The immune system may mediate anti-tumor responses in chronic lymphocytic leukemia (CLL) which may affect disease progression and survival. In this study, we analyzed the immune characteristics of 99 consecutive previously diagnosed CLL patients and
Externí odkaz:
https://doaj.org/article/69ba20661a304827a80ee746d4ac0b53